Project

Swiss Soliris® and Ultomiris® Reimbursement Registry SSURR: An observational registry for capturing data of patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) who are treated with Soliris® (eculizumab) or Ultomiris® (ravulizumab)

Ongoing - recruitment active · 2021 until 2030

Silzle Tobias, Demmer-Steingruber Ruth, Müller Fiona